No significant difference was observed between active and inactive SLE patient visits for IFN score (Figure 1A, mean ± SD, 62.7 ± 6.1 units versus 57.8 ± 4.9 units), ADAR (Figure 1C, 5.27 ± 0.31 fold versus 5.27 ± 0.23 fold), and CXCL10 (Figure 1E, 158.1-fold ± 26.6 versus 120.0-fold ± 10.5), but STAT1 (Figure 1B, 44.8 ± 10.7 vs 34.4 ± 6.6 fold, P = 0.033) and CCL2 (Figure 1D, 18.2-fold ± 3.1 versus 9.96-fold ± 1.42, P = 0.0061) were significantly elevated in active SLE compared to inactive SLE patient visits. This evidence concerns the gene CXCL10 and systemic lupus erythematosus.